Selected research
Industry Growth & Trends
Global Whole Plasmid Sequencing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Whole Plasmid Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Whole Plasmid Sequencing market include Eurofins Genomics, GenScript, Plasmidsaurus, Genewiz, Macrogen Europe, Source BioScience, Psomagen, BaseClear B.V. and Molecular Cloning Laboratories (MCLAB), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Whole Plasmid Sequencing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Whole Plasmid Sequencing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Whole Plasmid Sequencing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Whole Plasmid Sequencing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Whole Plasmid Sequencing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Whole Plasmid Sequencing Market by Company
Eurofins Genomics
GenScript
Plasmidsaurus
Genewiz
Macrogen Europe
Source BioScience
Psomagen
BaseClear B.V.
Molecular Cloning Laboratories (MCLAB)
Polyplus
Elim Biopharm
SnapGene
Full Circle Labs
Unveil Bio
Microsynth AG
CD Genomics
Whole Plasmid Sequencing Segment by Type
Plasmid Regular (2.5 – 25 kb)
Plasmid Large (25 – 125 kb)
Plasmid XL (125 – 300 kb)
Others
Whole Plasmid Sequencing Segment by Application
Biopharmaceutical Companies
Research Institutions
Others
Whole Plasmid Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Plasmid Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Plasmid Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Plasmid Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Whole Plasmid Sequencing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Plasmid Regular (2.5 – 25 kb)
- Plasmid Large (25 – 125 kb)
- Plasmid XL (125 – 300 kb)
- Others
Applications
- Biopharmaceutical Companies
- Research Institutions
- Others
Companies covered
- Eurofins Genomics
- GenScript
- Plasmidsaurus
- Genewiz
- Macrogen Europe
- Source BioScience
- Psomagen
- BaseClear B.V.
- Molecular Cloning Laboratories (MCLAB)
- Polyplus
- Elim Biopharm
- SnapGene
- Full Circle Labs
- Unveil Bio
- Microsynth AG
- CD Genomics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Whole Plasmid Sequencing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Whole Plasmid Sequencing Market Size by Region (2021-2032)
- 1.4.1 Global Whole Plasmid Sequencing Market Size by Region (2021-2026)
- 1.4.2 Global Whole Plasmid Sequencing Market Size by Region (2027-2032)
- 1.5 Key Regions Whole Plasmid Sequencing Market Size (2021-2032)
- 1.5.1 North America Whole Plasmid Sequencing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Whole Plasmid Sequencing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Whole Plasmid Sequencing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Whole Plasmid Sequencing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Whole Plasmid Sequencing Market Size Growth Rate (2021-2032)
2 Whole Plasmid Sequencing Market by Type
- 2.1 Type Introduction
- 2.1.1 Plasmid Regular (2.5 – 25 kb)
- 2.1.2 Plasmid Large (25 – 125 kb)
- 2.1.3 Plasmid XL (125 – 300 kb)
- 2.1.4 Others
- 2.2 Global Whole Plasmid Sequencing Market Size by Type
- 2.2.1 Global Whole Plasmid Sequencing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Whole Plasmid Sequencing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Whole Plasmid Sequencing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Whole Plasmid Sequencing Market Size by Regions
- 2.3.1 North America Whole Plasmid Sequencing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Whole Plasmid Sequencing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Whole Plasmid Sequencing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Whole Plasmid Sequencing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Whole Plasmid Sequencing Market Size Breakdown by Type (2021-2026)
3 Whole Plasmid Sequencing Market by Application
- 3.1 Type Introduction
- 3.1.1 Biopharmaceutical Companies
- 3.1.2 Research Institutions
- 3.1.3 Others
- 3.2 Global Whole Plasmid Sequencing Market Size by Application
- 3.2.1 Global Whole Plasmid Sequencing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Whole Plasmid Sequencing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Whole Plasmid Sequencing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Whole Plasmid Sequencing Market Size by Regions
- 3.3.1 North America Whole Plasmid Sequencing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Whole Plasmid Sequencing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Whole Plasmid Sequencing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Whole Plasmid Sequencing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Whole Plasmid Sequencing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Whole Plasmid Sequencing Industry Trends
- 4.2 Whole Plasmid Sequencing Industry Drivers
- 4.3 Whole Plasmid Sequencing Industry Opportunities and Challenges
- 4.4 Whole Plasmid Sequencing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Whole Plasmid Sequencing Revenue (2021-2026)
- 5.2 Global Whole Plasmid Sequencing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Whole Plasmid Sequencing Key Company Headquarters & Area Served
- 5.4 Global Whole Plasmid Sequencing Company, Product Type & Application
- 5.5 Global Whole Plasmid Sequencing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Whole Plasmid Sequencing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Whole Plasmid Sequencing Players Market Share by Revenue in 2025
- 5.6.3 2025 Whole Plasmid Sequencing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Eurofins Genomics
- 6.1.1 Eurofins Genomics Company Information
- 6.1.2 Eurofins Genomics Business Overview
- 6.1.3 Eurofins Genomics Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Eurofins Genomics Whole Plasmid Sequencing Product Portfolio
- 6.1.5 Eurofins Genomics Recent Developments
- 6.2 GenScript
- 6.2.1 GenScript Company Information
- 6.2.2 GenScript Business Overview
- 6.2.3 GenScript Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 GenScript Whole Plasmid Sequencing Product Portfolio
- 6.2.5 GenScript Recent Developments
- 6.3 Plasmidsaurus
- 6.3.1 Plasmidsaurus Company Information
- 6.3.2 Plasmidsaurus Business Overview
- 6.3.3 Plasmidsaurus Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Plasmidsaurus Whole Plasmid Sequencing Product Portfolio
- 6.3.5 Plasmidsaurus Recent Developments
- 6.4 Genewiz
- 6.4.1 Genewiz Company Information
- 6.4.2 Genewiz Business Overview
- 6.4.3 Genewiz Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Genewiz Whole Plasmid Sequencing Product Portfolio
- 6.4.5 Genewiz Recent Developments
- 6.5 Macrogen Europe
- 6.5.1 Macrogen Europe Company Information
- 6.5.2 Macrogen Europe Business Overview
- 6.5.3 Macrogen Europe Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Macrogen Europe Whole Plasmid Sequencing Product Portfolio
- 6.5.5 Macrogen Europe Recent Developments
- 6.6 Source BioScience
- 6.6.1 Source BioScience Company Information
- 6.6.2 Source BioScience Business Overview
- 6.6.3 Source BioScience Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Source BioScience Whole Plasmid Sequencing Product Portfolio
- 6.6.5 Source BioScience Recent Developments
- 6.7 Psomagen
- 6.7.1 Psomagen Company Information
- 6.7.2 Psomagen Business Overview
- 6.7.3 Psomagen Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Psomagen Whole Plasmid Sequencing Product Portfolio
- 6.7.5 Psomagen Recent Developments
- 6.8 BaseClear B.V.
- 6.8.1 BaseClear B.V. Company Information
- 6.8.2 BaseClear B.V. Business Overview
- 6.8.3 BaseClear B.V. Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 BaseClear B.V. Whole Plasmid Sequencing Product Portfolio
- 6.8.5 BaseClear B.V. Recent Developments
- 6.9 Molecular Cloning Laboratories (MCLAB)
- 6.9.1 Molecular Cloning Laboratories (MCLAB) Company Information
- 6.9.2 Molecular Cloning Laboratories (MCLAB) Business Overview
- 6.9.3 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Product Portfolio
- 6.9.5 Molecular Cloning Laboratories (MCLAB) Recent Developments
- 6.10 Polyplus
- 6.10.1 Polyplus Company Information
- 6.10.2 Polyplus Business Overview
- 6.10.3 Polyplus Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Polyplus Whole Plasmid Sequencing Product Portfolio
- 6.10.5 Polyplus Recent Developments
- 6.11 Elim Biopharm
- 6.11.1 Elim Biopharm Company Information
- 6.11.2 Elim Biopharm Business Overview
- 6.11.3 Elim Biopharm Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Elim Biopharm Whole Plasmid Sequencing Product Portfolio
- 6.11.5 Elim Biopharm Recent Developments
- 6.12 SnapGene
- 6.12.1 SnapGene Company Information
- 6.12.2 SnapGene Business Overview
- 6.12.3 SnapGene Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 SnapGene Whole Plasmid Sequencing Product Portfolio
- 6.12.5 SnapGene Recent Developments
- 6.13 Full Circle Labs
- 6.13.1 Full Circle Labs Company Information
- 6.13.2 Full Circle Labs Business Overview
- 6.13.3 Full Circle Labs Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Full Circle Labs Whole Plasmid Sequencing Product Portfolio
- 6.13.5 Full Circle Labs Recent Developments
- 6.14 Unveil Bio
- 6.14.1 Unveil Bio Company Information
- 6.14.2 Unveil Bio Business Overview
- 6.14.3 Unveil Bio Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Unveil Bio Whole Plasmid Sequencing Product Portfolio
- 6.14.5 Unveil Bio Recent Developments
- 6.15 Microsynth AG
- 6.15.1 Microsynth AG Company Information
- 6.15.2 Microsynth AG Business Overview
- 6.15.3 Microsynth AG Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Microsynth AG Whole Plasmid Sequencing Product Portfolio
- 6.15.5 Microsynth AG Recent Developments
- 6.16 CD Genomics
- 6.16.1 CD Genomics Company Information
- 6.16.2 CD Genomics Business Overview
- 6.16.3 CD Genomics Whole Plasmid Sequencing Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 CD Genomics Whole Plasmid Sequencing Product Portfolio
- 6.16.5 CD Genomics Recent Developments
7 North America
- 7.1 North America Whole Plasmid Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 7.3 North America Whole Plasmid Sequencing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Whole Plasmid Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 8.3 Europe Whole Plasmid Sequencing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Whole Plasmid Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Whole Plasmid Sequencing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Whole Plasmid Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 10.3 South America Whole Plasmid Sequencing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Whole Plasmid Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Whole Plasmid Sequencing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst